These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 23728104)

  • 1. Time-dependent effects of sclerostin antibody on a mouse fracture healing model.
    Cui L; Cheng H; Song C; Li C; Simonet WS; Ke HZ; Li G
    J Musculoskelet Neuronal Interact; 2013 Jun; 13(2):178-84. PubMed ID: 23728104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sclerostin monoclonal antibody enhanced bone fracture healing in an open osteotomy model in rats.
    Suen PK; He YX; Chow DH; Huang L; Li C; Ke HZ; Ominsky MS; Qin L
    J Orthop Res; 2014 Aug; 32(8):997-1005. PubMed ID: 24782158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic administration of sclerostin monoclonal antibody accelerates fracture healing in the femoral osteotomy model of young rats.
    Feng G; Chang-Qing Z; Yi-Min C; Xiao-Lin L
    Int Immunopharmacol; 2015 Jan; 24(1):7-13. PubMed ID: 25479724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Sclerostin Antibody on the Healing of Femoral Fractures in Ovariectomised Rats.
    Liu Y; Rui Y; Cheng TY; Huang S; Xu L; Meng F; Lee WY; Zhang T; Li N; Li C; Ke H; Li G
    Calcif Tissue Int; 2016 Mar; 98(3):263-74. PubMed ID: 26603303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sclerostin Antibody Increases Callus Size and Strength but does not Improve Fracture Union in a Challenged Open Rat Fracture Model.
    Morse A; McDonald MM; Schindeler A; Peacock L; Mikulec K; Cheng TL; Liu M; Ke HZ; Little DG
    Calcif Tissue Int; 2017 Aug; 101(2):217-228. PubMed ID: 28391431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does Sclerostin Depletion Stimulate Fracture Healing in a Mouse Model?
    Alzahrani MM; Rauch F; Hamdy RC
    Clin Orthop Relat Res; 2016 May; 474(5):1294-302. PubMed ID: 26608966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of sclerostin by monoclonal antibody enhances bone healing and improves bone density and strength of nonfractured bones.
    Ominsky MS; Li C; Li X; Tan HL; Lee E; Barrero M; Asuncion FJ; Dwyer D; Han CY; Vlasseros F; Samadfam R; Jolette J; Smith SY; Stolina M; Lacey DL; Simonet WS; Paszty C; Li G; Ke HZ
    J Bone Miner Res; 2011 May; 26(5):1012-21. PubMed ID: 21542004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of sclerostin antibody on healing of a non-critical size femoral bone defect.
    Jawad MU; Fritton KE; Ma T; Ren PG; Goodman SB; Ke HZ; Babij P; Genovese MC
    J Orthop Res; 2013 Jan; 31(1):155-63. PubMed ID: 22887736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Micro-computed tomography assessment of the progression of fracture healing in mice.
    O'Neill KR; Stutz CM; Mignemi NA; Burns MC; Murry MR; Nyman JS; Schoenecker JG
    Bone; 2012 Jun; 50(6):1357-67. PubMed ID: 22453081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic Administration of Sclerostin Antibody Enhances Bone Morphogenetic Protein-Induced Femoral Defect Repair in a Rat Model.
    Tinsley BA; Dukas A; Pensak MJ; Adams DJ; Tang AH; Ominsky MS; Ke HZ; Lieberman JR
    J Bone Joint Surg Am; 2015 Nov; 97(22):1852-9. PubMed ID: 26582615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sclerostin Neutralizing Antibody Treatment Enhances Bone Formation but Does Not Rescue Mechanically Induced Delayed Healing.
    Kruck B; Zimmermann EA; Damerow S; Figge C; Julien C; Wulsten D; Thiele T; Martin M; Hamdy R; Reumann MK; Duda GN; Checa S; Willie BM
    J Bone Miner Res; 2018 Sep; 33(9):1686-1697. PubMed ID: 29694687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of 1,25-dihydroxy vitamin D3 on fracture healing and bone remodeling in ovariectomized rat femora.
    Fu L; Tang T; Miao Y; Hao Y; Dai K
    Bone; 2009 May; 44(5):893-8. PubMed ID: 19442605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovariectomy-Induced Osteopenia Influences the Middle and Late Periods of Bone Healing in a Mouse Femoral Osteotomy Model.
    Pang J; Ye M; Gu X; Cao Y; Zheng Y; Guo H; Zhao Y; Zhan H; Shi Y
    Rejuvenation Res; 2015 Aug; 18(4):356-65. PubMed ID: 25694054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual Inhibition of the Wnt Inhibitors DKK1 and Sclerostin Promotes Fracture Healing and Increases the Density and Strength of Uninjured Bone: An Experimental Study in Nonhuman Primates.
    Florio M; Kostenuik PJ; Stolina M; Asuncion FJ; Grisanti M; Ke HZ; Ominsky MS
    J Bone Joint Surg Am; 2023 Aug; 105(15):1145-1155. PubMed ID: 37159527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic administration of sclerostin antibody enhances bone repair in a critical-sized femoral defect in a rat model.
    Virk MS; Alaee F; Tang H; Ominsky MS; Ke HZ; Lieberman JR
    J Bone Joint Surg Am; 2013 Apr; 95(8):694-701. PubMed ID: 23595067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone matrix quality after sclerostin antibody treatment.
    Ross RD; Edwards LH; Acerbo AS; Ominsky MS; Virdi AS; Sena K; Miller LM; Sumner DR
    J Bone Miner Res; 2014 Jul; 29(7):1597-607. PubMed ID: 24470143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sclerostin Antibody Augments the Anabolic Bone Formation Response in a Mouse Model of Mechanical Tibial Loading.
    Morse A; Schindeler A; McDonald MM; Kneissel M; Kramer I; Little DG
    J Bone Miner Res; 2018 Mar; 33(3):486-498. PubMed ID: 29090474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human parathyroid hormone (1-34) accelerates natural fracture healing process in the femoral osteotomy model of cynomolgus monkeys.
    Manabe T; Mori S; Mashiba T; Kaji Y; Iwata K; Komatsubara S; Seki A; Sun YX; Yamamoto T
    Bone; 2007 Jun; 40(6):1475-82. PubMed ID: 17369013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sclerostin-antibody treatment of glucocorticoid-induced osteoporosis maintained bone mass and strength.
    Yao W; Dai W; Jiang L; Lay EY; Zhong Z; Ritchie RO; Li X; Ke H; Lane NE
    Osteoporos Int; 2016 Jan; 27(1):283-294. PubMed ID: 26384674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sclerostin antibody reduces long bone fractures in the oim/oim model of osteogenesis imperfecta.
    Cardinal M; Tys J; Roels T; Lafont S; Ominsky MS; Devogelaer JP; Chappard D; Mabilleau G; Ammann P; Nyssen-Behets C; Manicourt DH
    Bone; 2019 Jul; 124():137-147. PubMed ID: 31051315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.